3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
22
Lung Neoplasms
11
Brain Neoplasms
4
Rare Tumor
1
Radiation Pneumonitis
1
Non-small Cell Lung Cancer Metastatic
1
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
1
Meningeal Carcinomatosis
1
Liver Diseases
1
EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
1
Digestive System Diseases
1
Carcinoma
1
Aumolertinib
1
Advanced Non-small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
palbociclib
1
aumolertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
×
aumolertinib
×
Clear all
NCT06947811
2025-06-04
APEAK
Sun Yat-sen University
Phase 1/2
Recruiting
71 enrolled